Housed at the Vancouver Prostate Centre, PC-TRiADD’s world-class research aims to understand mechanisms of treatment resistance in advanced prostate cancer and translate that into new services and products to improve cancer outcomes.Read more
Leveraging its research expertise, core facilities and project management experience, PC-TRiADD offers pharmaceutical companies, biotech companies and researchers a variety of translational research services including Pre-clinical Pharmacology, Molecular Pathology, Genomic Analysis and Clinical Trials.
PC-TRiADD, a translational research initiative of the Vancouver Prostate Centre, is dedicated to improving outcomes in prostate cancer. PC-TRiADD host institutions are the Vancouver Coastal Health Research Institute and the Department of Urologic Sciences in the Faculty of Medicine at the University of British Columbia.Read more
As with any successful research enterprise the key to success is establishing and maintaining strong networks and partnerships with local, national, and international collaborators, as well as funders, patients and benefactors.Read more
A potential therapeutic for advanced prostate cancer developed at the Vancouver Prostate Centre by Drs. Cherkasov and Rennie has been licensed to Roche, marking UBC’s largest licensing agreement to date.